Biotissue

BioTissue specializes in regenerative medicine, focusing on the development and commercialization of advanced wound care and surgical solutions derived from human amniotic membrane tissue. They generate revenue through the sale of their proprietary products, which are used in ophthalmology, orthopedics, and chronic wound care. Founded in 1997, BioTissue has pioneered several innovative treatments, including their flagship product, AmnioGraft, which has set industry standards for ocular surface reconstruction.

Recent Posts by Biotissue

1-20 of 96